{
    "nctId": "NCT06559371",
    "briefTitle": "68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer",
    "officialTitle": "68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "BREAST CANCER, PET/CT",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "Sensitivity and specificity of 68Ga FAPI PET/CT in predicting residual axillary lymph node lesions after neoadjuvant therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients aged 18 and above\n* ECOG score 0-2 points\n* Pathological confirmation of malignant breast tumor\n* Clinical axillary lymph node positivity (cN+)\n* Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment\n* Informed consent form signed\n\nExclusion Criteria:\n\n* Distant metastasis\n* Unable to complete the proposed neoadjuvant therapy plan\n* Pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}